Contemporary Amperex Technology Co (CYATY) Fair Value & Analysis
Industrials · US · Market cap $418B
Analysis
Contemporary Amperex Technology Co (CYATY) currently trades at $22.68, while our model-based Fair Value estimate is $11.92 — implying the stock looks roughly 47.4% overvalued today. We read business quality at 86/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
Contemporary Amperex Technology Co., Limited, together with its subsidiaries, engages in the research, development, production, and sale of electric vehicle and energy storage system batteries in China and internationally. The company offers power battery systems, including cells, modules/battery boxes, and battery packs, as well as lithium iron phosphate, ternary high-voltage medium-nickel, ternary high-nickel, super hybrid, sodium-ion, and condensed matter batteries; energy storage battery systems, such as cells, battery cabinets, energy storage containers, and system integration; and battery material products comprising lithium salts, precursors, and cathode materials. It also processes, purifies, and synthesizes metal materials, which include nickel, cobalt, manganese, lithium, phosphorus, iron, aluminum, copper, and other materials from spent batteries. In addition, the company provides passenger vehicles solutions, such as electric private and operating vehicles, as well as hy…
Open the full interactive analysis →
Similar stocks
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.